Start-Up News June 2007

New incubators are helping to fill a resource gap between universities looking for homes for their early stage medical device technologies and individual entrepreneurs looking to move their innovative projects out of the garage.

For universities looking for homes for their early stage medical device technologies and individual entrepreneurs looking to move their innovative ideas out of the garage, a resource gap exists that new incubators are helping to fill. Namely, early stage device innovators need funding to build prototypes, conduct proof-of-concept in animal models, and create an infrastructure to support development efforts that will move technologies up the value chain to the point where venture capitalists will consider investing in them. Now, new incubators, working with universities (but not necessarily owned or run by them) and local economic development agencies are springing up with the mission of starting and sheltering early stage device companies so they can reach the first important milestone of an external founding round. (See, "The New Device Incubators," START-UP, June 2007 Also see "The New Device Incubators" - Scrip, 1 June, 2007.). These new organizations not only extend the capabilities of traditional technology transfer by creating new companies around university IP, but also serve other aims like regional economic development, or providing a training ground for students, in attracting companies formed out in the community to university incubators.

The University of Massachusetts, for example, recently started up a medical device incubator called M2D2 (for Massachusetts Medical Device Development Center) on its Lowell engineering campus, with $135,000 in seed...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By 

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By 

Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.

Patients With Movement Disorders Will Benefit From Medtronic’s Expanded MRI Labeling For DBS

 
• By 

Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.

Podcast: Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic

 

In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.

More from Medtech Insight

Edwards Lifesciences Holds 2025 EPS Outlook Despite Tariff Headwind

 
• By 

The brunt of the tariff exposure stems from Singapore and Costa Rica, which together account for an estimated 70% to 80% of the tariff-related cost burden. Less than 10% of the exposure is tied to China.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.